Related references
Note: Only part of the references are listed.A Large Animal Model of Spinal Muscular Atrophy and Correction of Phenotype
Sandra I. Duque et al.
ANNALS OF NEUROLOGY (2015)
Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
Yimin Hua et al.
GENES & DEVELOPMENT (2015)
Motoneuron development influences dorsal root ganglia survival and Schwann cell development in a vertebrate model of spinal muscular atrophy
Le Thi Hao et al.
HUMAN MOLECULAR GENETICS (2015)
Spinal Muscular Atrophy: Therapeutic Strategies
Diana Castro et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy
Gillian Hunter et al.
HUMAN MOLECULAR GENETICS (2014)
Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
Erkan Y. Osman et al.
HUMAN MOLECULAR GENETICS (2014)
Defining the therapeutic window in a severe animal model of spinal muscular atrophy
Kate L. Robbins et al.
HUMAN MOLECULAR GENETICS (2014)
Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?
Monir Shababi et al.
JOURNAL OF ANATOMY (2014)
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Nikolai A. Naryshkin et al.
SCIENCE (2014)
Gene therapy enters the pharma market: The short story of a long journey
Hildegard Buening
EMBO MOLECULAR MEDICINE (2013)
Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy
Jafar Mohseni et al.
GENETICS AND MOLECULAR BIOLOGY (2013)
A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
Haiyan Zhou et al.
HUMAN GENE THERAPY (2013)
Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy
Melissa S. Cobb et al.
HUMAN MOLECULAR GENETICS (2013)
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Paul N. Porensky et al.
HUMAN MOLECULAR GENETICS (2012)
Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy
Karen K. Y. Ling et al.
HUMAN MOLECULAR GENETICS (2012)
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
Elisa Dominguez et al.
HUMAN MOLECULAR GENETICS (2011)
Population Carrier Screening for Spinal Muscular Atrophy A Position Statement of the Association for Molecular Pathology
Kasinathan Muralidharan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Early Functional Impairment of Sensory-Motor Connectivity in a Mouse Model of Spinal Muscular Atrophy
George Z. Mentis et al.
NEURON (2011)
Design principles for bifunctional targeted oligonucleotide enhancers of splicing
Nicholas Owen et al.
NUCLEIC ACIDS RESEARCH (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
Marco A. Passini et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
DIGITAL NECROSES AND VASCULAR THROMBOSIS IN SEVERE SPINAL MUSCULAR ATROPHY
Sabine Rudnik-Schoeneborn et al.
MUSCLE & NERVE (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy
Karen K. Y. Ling et al.
PLOS ONE (2010)
Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
Chiara F. Valori et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
Jan Hauke et al.
HUMAN MOLECULAR GENETICS (2009)
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate
Lutz Garbes et al.
HUMAN MOLECULAR GENETICS (2009)
Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy
Alexandra Prufer de Queiroz Campos Araujo et al.
JOURNAL OF PEDIATRICS (2009)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of histone acetylation in SMN gene expression
LE Kernochan et al.
HUMAN MOLECULAR GENETICS (2005)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
L Cartegni et al.
NATURE GENETICS (2002)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)
Share Paper
